Drug General Information
Drug ID	D05ACE
Former ID	DNC013973
Drug Name	1,5-bis(4-chlorophenyl)-1H-1,2,3-triazole
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529882]
Structure		Download 2D MOL 3D MOL
Formula	C14H9Cl2N3
Canonical SMILES	C1=CC(=CC=C1C2=CN=NN2C3=CC=C(C=C3)Cl)Cl
InChI	1S/C14H9Cl2N3/c15-11-3-1-10(2-4-11)14-9-17-18-19(14)13-7-5-12(16)6-8-13/h1-9H
InChIKey	RXDUBIUDBWNEMF-UHFFFAOYSA-N
PubChem Compound ID	44572111
Target and Pathway
Target(s)	Cannabinoid receptor 1	Target Info	Inhibitor	[529882]
KEGG Pathway	Rap1 signaling pathway
	Neuroactive ligand-receptor interaction
	Retrograde endocannabinoid signaling
PANTHER Pathway	Endogenous cannabinoid signaling
Pathway Interaction Database	N-cadherin signaling events
Reactome	Class A/1 (Rhodopsin-like receptors)
	G alpha (i) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Small Ligand GPCRs
	BDNF signaling pathway
	GPCR ligand binding
	GPCR downstream signaling
	GPCRs, Other
References
Ref 529882	Bioorg Med Chem Lett. 2009 Feb 1;19(3):891-3. Epub 2008 Dec 6.Synthesis and CB1 cannabinoid receptor affinity of 4-alkoxycarbonyl-1,5-diaryl-1,2,3-triazoles.
Ref 529882	Bioorg Med Chem Lett. 2009 Feb 1;19(3):891-3. Epub 2008 Dec 6.Synthesis and CB1 cannabinoid receptor affinity of 4-alkoxycarbonyl-1,5-diaryl-1,2,3-triazoles.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.